CAR-T Companies Hang Onto Novartis' Coat-Tails After Historic FDA Panel Vote

 
• By Kevin Grogan
Human tower
Standing strong: FDA panel nod may boost other CAR-T players • Source: Shutterstock

More from Immuno-oncology

More from Anticancer